Clinical trial
A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in…
NCT00221325 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00221325 |
|---|---|
| Title | A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma |
| Official title | Phase I Study of Intraventricular Administration of Rituximab in Combination With Methotrexate in the Treatment of Recurrent CNS and Intraocular Lymphoma |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Central Nervous System Lymphoma, Intraocular Lymphoma |
| Intervention type | Drug |
| Interventions | Intraventricular Rituximab Plus MTX |
| Enrollment | 14 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2012 |
| Completion | Mar 1, 2013 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 16, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: